About IDDI
We are an expert clinical data services and high-level strategic consulting contract research organization (CRO), providing agile clinical trials services for pharmaceutical, biotech, and medical device/diagnostic companies.
With a proven track record, IDDI provides expert Biostatistics and eClinical Services to ensure the successful execution of your clinical development program.
Passion. Science. Experience.
A passionate and experienced science-led team, committed to delivering submission-ready clinical data.
Meet Our TeamCommitment to Quality and Precision
“IDDI was of great benefit, particularly with respect to their responsiveness, their commitment to quality and precision, and their ability to meet our very ambitious timelines.”
Jim Taylor, CEO Oraya Therapeutics, Newark, CA, USA
How IDDI Adds Value to Your Clinical Data
Strategic-level consultancy to optimize your clinical development program even in clinical trials with complex settings.
Delivered by talented, forward-thinking and science-led professionals, who will take ownership of your needs.
Over 30 years in business ensuring continuity in your clinical development.
IDDI’s culture is scientifically driven, thanks to its founder and Chief Scientific Officer, Marc Buyse, CEO.
Expert clinical data services (EDC/RTSM/Medical Coding) providing flexible solutions for collection, standardization, analysis, documentation and reporting of your clinical data.
A Project Manager is assigned to every project. Flexibility, responsiveness, proactiveness are skills often mentioned by our customers.
Experienced contract research organization with a solid understanding of the clinical development process and breadth of therapeutic areas expertise.
Thanks to a strong collaborative approach with Academics and Key Opinion Leaders.
Resource Library
Discover our on-demand recorded webinars, podcasts, videos and scientific articles.
Videos ›
Webinars ›
Podcasts ›
Scientific Articles ›
Brochures ›
Fast growing company – Rewarding career. Join us and contribute to the progress of clinical research. An inspiring and exciting career with international and challenging projects is waiting for you!
Join UsAugust 26, 2021
Webinar: Randomization and the Limits of Precision Oncology
Join IDDI for a webinar on Thursday August 26, 2021 – Time: 10:00 – 11:00 CEST How to strike the…
View WebinarBiostatistics and SARS-CoV-2: research, policymaking, and communication
Learn on the central role of Biostatistics in the COVID-19 Pandemia, and the multidisciplinary nature of pandemic response Join us…
Webinar: Randomization and the Limits of Precision Oncology
Join IDDI for a webinar on Thursday August 26, 2021 – Time: 10:00 – 11:00 CEST How to strike the…
IDDI at the PCMG Annual Conference 2021
Join IDDI at PCMG 2021 Erik Falvey, Sr. Director BD Europe IDDI will be there virtually! Want to set up…
IDDI at NLSDays 2021
Join IDDI at NLSDays 2021! Nordic Life Science Days is the largest Nordic partnering conference dedicated to the life science…
IDDI Speaker at DIA 2021
Listen to Marc Buyse, ScD speaker at the DIA Global Meeting 2021 His talk is entitled ‘Randomized Controlled Trials (RCTs): Lessons…
IDDI Speaker at the Precision Medicine and Health Technology Assessment Webinar
TOPICS OF THE PRECISION MEDICINE AND HTA ASSESSMENT WEBINAR Precision medicine aims to tailor disease prevention, diagnosis and treatment to…
IDDI speaker at 2021 ASA Regulatory Industry Statistics Workshop (RISW)
Marc Buyse, ScD, plenary panel session speaker at the ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop. The plenary panel discussion topic…
IDDI speaking at the Annual Meeting of the Society for Clinical Trials (SCT)
IDDI presenting two sessions at the Clinical Trials Annual Meeting The 42ND ANNUAL MEETING of the Society for Clinical Trials…
Drug Development in Oncology in the Era of Precision Medicine
Cancer research is complex: trials require specific design expertise and often include biomarker and companion diagnostics, and failure rates tend…
The Importance of Early Phase Trials in Precision Oncology
Nowadays, drug development in oncology is largely centered on the basic premise of precision medicine, according to which targeted agents…